Eloxx Pharmaceuticals (ELOX, $0.7) was a top loser over the last three months, falling -2 to $0.7 per share. A.I.dvisor analyzed 881 stocks in the Biotechnology Industry for the 3-month period ending July 16, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.